Vision

Our vision: to advance beyond state-of-the-art solutions in bone repair

With the successful completion of the cmRNAbone project, we have developed an innovative gene therapy for bone regeneration, aimed at improving the lives of patients with large traumatic injuries or bone degenerative diseases such as osteoporosis. The project has advanced beyond state-of-the-art technologies, creating a paradigm shift in how osteoporosis and large bone defects are treated.

The novel therapeutic strategy proposed by cmRNAbone has fostered an ecosystem for the translation of regenerative medicine by combining groundbreaking fields such as cmRNA technology, nanomedicine, 3D bioprinting, bioinks, and hydrogels/scaffolds.

During the project, significant strides were made in advancing 3D bioprinting technology, with tailored equipment adapted for hospital use, ensuring sterility and incorporating easy-to-handle, disposable cartridges. Moreover, the use of RNA molecules offers substantial environmental benefits by reducing energy consumption during production and minimizing the impact of pharmaceuticals on marine life.